HJURP and pancreatic ductal adenocarcinoma: Wang et al. reported that HJURP is highly expressed in clinical pancreatic ductal adenocarcinoma (PDAC) tissues, and that patients with high tumoral HJURP levels have significantly poorer survival compared to patients with low HJURP (Table 1).